The Company is a company formed for the sole purpose of merging with existing corporations. The Company focuses its merger targets in renewable energy industry; bio pharmaceutical and medical device industry; secondary battery industry; light emitting diode (LED) application industry; green transportation system industry; carbon abatement energy industry; advanced water treatment industry; digital content, games and entertainment industries; robot application industry; new material and nano convergence industry; high value added food industry; automobile parts manufacturing industry; information technology (IT) and semiconductor industries, as well as other industries considered to have future growth engines. The Company was established on September 11, 2018. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on December 19, 2018.
Headquarters
343, Samil-Daero, Jung-Gu
Seoul; Seoul;
Contact Details: Purchase the Kukjeon Pharmaceutical Co. Ltd. report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service